Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1370336 | Bioorganic & Medicinal Chemistry Letters | 2013 | 4 Pages |
Abstract
A series of novel 6-(aminomethylphenoxy)benzoxaborole analogs was synthesized for the investigation of the structure–activity relationship of the inhibition of TNF-alpha, IL-1beta, and IL-6, from lipopolysaccharide stimulated peripheral blood mononuclear cells. Compounds 9d and 9e showed potent activity against all three cytokines with IC50 values between 33 and 83 nM. Chloro substituted analog 9e (AN3485) is considered to be a promising lead for novel anti-inflammatory agent with a favorable pharmacokinetic profile.
Graphical abstractCytokine release inhibitory activity and pharmacokinetics of novel benzoxaborole derivatives are reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Tsutomu Akama, Charlotte Virtucio, Chen Dong, Richard Kimura, Yong-Kang Zhang, James A. Nieman, Rashmi Sharma, Xiaosong Lu, Marcelo Sales, Rajeshwar Singh, Anne Wu, Xiao-Qing Fan, Liang Liu, Jacob J. Plattner, Kurt Jarnagin, Yvonne R. Freund,